Efficacy and safety of anti-vascular endothelial growth factor agents on corneal neovascularization: A meta-analysis

BACKGROUND: Corneal neovascularization (CoNV) is the second major cause of blindness. Vascular endothelial growth factor (VEGF) inhibitors, e.g., bevacizumab, have been used to prevent CoNV. AIM: We conducted an updated systematic review and meta-analysis of clinical trials to examine the efficacy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Shih-Chung, Loh, El-Wui, Chiou, Du-I, Hong, Chien-Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643059/
https://www.ncbi.nlm.nih.gov/pubmed/37969435
http://dx.doi.org/10.12998/wjcc.v11.i30.7337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643059/
https://www.ncbi.nlm.nih.gov/pubmed/37969435
http://dx.doi.org/10.12998/wjcc.v11.i30.7337

Ejemplares similares